Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

41 recalls, newest first

Class II · Moderate risk

Famotidine Tablets

Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.

Terminated Labeling / mix-up Glenmark Therapeutics, Inc. NDC 72657-113-20 D-0939-2023
Class III · Low risk

Gabapentin Tablets

Product mixup: one foreign tablet found in product.

Terminated Labeling / mix-up The Harvard Drug Group NDC 0904-6823-61 D-0570-2023
Class I · High risk

G-Supress DX

Product mix-up: incorrect product was found inside the G-Supress DX product carton.

Terminated Labeling / mix-up Novis PR, LLC dba Kramer Novis NDC 52083-655-01 D-0868-2023
Class III · Low risk

Lidocaine Patch 5%

Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. D-0556-2023
Class III · Low risk

Bevacizumab 2.5 mg/0.1 mL

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

Terminated Labeling / mix-up Pine Pharmaceuticals, LLC NDC 69194-0458-1 D-0531-2023
Class III · Low risk

MEKTOVI (binimetinib)

Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

Ongoing Labeling / mix-up Pfizer Inc. D-0532-2023
Class III · Low risk

Levofloxacin Tablets

Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.

Terminated Labeling / mix-up Macleods Pharma USA, INC NDC 33342-022-08 D-0162-2023

Recalls by year